Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00296-021-04792-9 http://scihub22266oqcxt.onion/10.1007/s00296-021-04792-9 33515320!7846902!33515320     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Rheumatol+Int 2021 ; 41 (3): 509-518 Nephropedia Template TP {{tp|p=33515320|t=2021. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis |pdf=|usr=}}{{33515320}} gab.com Text SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis JO: Rheumatol Int http://www.kidney.de/pget.php?&tw=1&pmid=33515320 #FOAvip Coronavirus disease 2019 (COVID-19) pandemic has become challenging even for the most durable healthcare systems. It seems that vaccination, one of the most effective public-health interventions, presents a ray of hope to end the pandemic by achieving herd immunity. In this review, we aimed to cover aspects of the current knowledge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and vaccine candidates in the light of autoimmune inflammatory diseases (AIIDs) and to analyze their potential in terms of safety and effectiveness in patients with AIIDs. Therefore, a focused narrative review was carried out to predict the possible implications of different types of SARS-CoV-2 vaccines which confer distinct immune mechanisms to establish immune response and protection against COVID-19: whole virus (inactivated or weakened), viral vector (replicating and non-replicating), nucleic acid (RNA, DNA), and protein-based (protein subunit, virus-like particle). Still, there is uncertainty among patients with AIIDs and clinicians about the effectiveness and safety of the new vaccines. There are a variety of approaches towards building a protective immunity against SARS-CoV-2. Only high-quality clinical trials would clarify the underlying immunological mechanisms of the newly implemented vaccines/adjuvants in patients living with AIIDs. Twit Text FOAVip SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis ????Rheumatol Int http://www.kidney.de/pget.php?&tw=1&pmid=33515320 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33515320 #FOAvip English Wikipedia <ref>{{Cite pmid|33515320}}</ref> SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis #MMPMID33515320 Velikova T; Georgiev T Rheumatol Int 2021[Mar]; 41 (3): 509-518 PMID33515320show ga Coronavirus disease 2019 (COVID-19) pandemic has become challenging even for the most durable healthcare systems. It seems that vaccination, one of the most effective public-health interventions, presents a ray of hope to end the pandemic by achieving herd immunity. In this review, we aimed to cover aspects of the current knowledge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and vaccine candidates in the light of autoimmune inflammatory diseases (AIIDs) and to analyze their potential in terms of safety and effectiveness in patients with AIIDs. Therefore, a focused narrative review was carried out to predict the possible implications of different types of SARS-CoV-2 vaccines which confer distinct immune mechanisms to establish immune response and protection against COVID-19: whole virus (inactivated or weakened), viral vector (replicating and non-replicating), nucleic acid (RNA, DNA), and protein-based (protein subunit, virus-like particle). Still, there is uncertainty among patients with AIIDs and clinicians about the effectiveness and safety of the new vaccines. There are a variety of approaches towards building a protective immunity against SARS-CoV-2. Only high-quality clinical trials would clarify the underlying immunological mechanisms of the newly implemented vaccines/adjuvants in patients living with AIIDs. |Autoimmune Diseases/epidemiology/*immunology[MESH] |COVID-19 Vaccines/adverse effects/*classification[MESH] |COVID-19/epidemiology/*prevention & control[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Risk Assessment[MESH]SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis(epmc).pdf DeepDyve Pubget Overpricing